Genital Diseases, Female  >>  Qinprezo (vosaroxin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Qinprezo (vosaroxin) / Denovo
NCT00408603: Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer

Completed
2
183
US, Canada
Voreloxin Injection, SNS-595, vosaroxin, Qinprezo
Sunesis Pharmaceuticals
Epithelial Ovarian Cancer
06/10
06/10

Download Options